Travere Therapeutics, Inc. (NASDAQ:TVTX) Q4 2022 Earnings Call Transcript February 23, 2023
Operator: Good day, and welcome to the Travere Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update. Today’s conference call is being recorded. At this time, I would like to turn the conference call over to the Vice President of Investor Relations, Naomi Eichenbaum. Please go ahead, Naomi. Thank you.
Naomi Eichenbaum: Thank you, Rachel. Good afternoon, and welcome to...
